Meeting
2011 ASCO Annual Meeting
Fiducial-less stereotactic radiotherapy for early-stage lung cancer: Efficacy and toxicity evaluation.
Authors
J. Bibault
Oscar Lambret Comprehensive Cancer Center, Lille, France
J. Bibault , B. Prevost , E. Dansin , X. Mirabel , T. Lacornerie , F. Dubus , E. Lartigau
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Local-regional and Adjuvant Therapy/Small Cell
Track
Lung Cancer
Sub Track
Local-Regional Therapy
Citation
J Clin Oncol 29: 2011 (suppl; abstr 7050)
Abstract #
7050
Poster Bd #
22F
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer.
First Author: Elizabeth Charlotte Moser
Poster
2019 ASCO Annual Meeting
Adaptive Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in combination with GC4419 in pancreatic cancer.
First Author: Jon Holmlund
Poster
2024 ASCO Genitourinary Cancers Symposium
Long-term treatment outcomes from the International Multi-Institutional Stereotactic Body Radiation Therapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium.
First Author: Luca Faustino Valle
Poster
2019 ASCO Annual Meeting
Phase II multi-institutional study of nivolumab (Nivo), cabiralizumab (Cabira), and stereotactic body radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer (LAUPC).
First Author: Deirdre Jill Cohen